These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25271316)

  • 21. Remodeling of dystrophin and sarcomeric Z-band occurs in pediatric cardiomyopathies: a unifying mechanism for force transmission defect.
    Vatta M; Sinagra G; Brunelli L; Faulkner G
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):149-56. PubMed ID: 19194174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hereditary cardiomyopathies: a review. Mutation of structural proteins a common cause of hereditary cardiomyopathy].
    Sjöberg G; Kostareva A; Sejersen T
    Lakartidningen; 2005 Mar 14-20; 102(11):845-7, 850-3. PubMed ID: 15835520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the sarcomere to correct muscle function.
    Hwang PM; Sykes BD
    Nat Rev Drug Discov; 2015 May; 14(5):313-28. PubMed ID: 25881969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The genetic basis for cardiac remodeling.
    Ahmad F; Seidman JG; Seidman CE
    Annu Rev Genomics Hum Genet; 2005; 6():185-216. PubMed ID: 16124859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertrophic cardiomyopathy: from gene defect to clinical disease.
    Chung MW; Tsoutsman T; Semsarian C
    Cell Res; 2003 Feb; 13(1):9-20. PubMed ID: 12643345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy.
    Hoedemaekers YM; Caliskan K; Michels M; Frohn-Mulder I; van der Smagt JJ; Phefferkorn JE; Wessels MW; ten Cate FJ; Sijbrands EJ; Dooijes D; Majoor-Krakauer DF
    Circ Cardiovasc Genet; 2010 Jun; 3(3):232-9. PubMed ID: 20530761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research priorities in sarcomeric cardiomyopathies.
    van der Velden J; Ho CY; Tardiff JC; Olivotto I; Knollmann BC; Carrier L
    Cardiovasc Res; 2015 Apr; 105(4):449-56. PubMed ID: 25631582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac myosin binding protein C: its role in physiology and disease.
    Flashman E; Redwood C; Moolman-Smook J; Watkins H
    Circ Res; 2004 May; 94(10):1279-89. PubMed ID: 15166115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcomere protein gene mutations and inherited heart disease: a beta-cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure.
    Kamisago M; Schmitt JP; McNamara D; Seidman C; Seidman JG
    Novartis Found Symp; 2006; 274():176-89; discussion 189-95, 272-6. PubMed ID: 17019812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes.
    Pohlmann L; Kröger I; Vignier N; Schlossarek S; Krämer E; Coirault C; Sultan KR; El-Armouche A; Winegrad S; Eschenhagen T; Carrier L
    Circ Res; 2007 Oct; 101(9):928-38. PubMed ID: 17823372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic engineering and therapy for inherited and acquired cardiomyopathies.
    Day S; Davis J; Westfall M; Metzger J
    Ann N Y Acad Sci; 2006 Oct; 1080():437-50. PubMed ID: 17132800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle.
    Vikhorev PG; Vikhoreva NN
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Troponin and cardiomyopathy.
    Chang AN; Parvatiyar MS; Potter JD
    Biochem Biophys Res Commun; 2008 Apr; 369(1):74-81. PubMed ID: 18157941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular noncompaction and cardiomyopathy: cause, contributor, or epiphenomenon?
    Sen-Chowdhry S; McKenna WJ
    Curr Opin Cardiol; 2008 May; 23(3):171-5. PubMed ID: 18382203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric restrictive cardiomyopathy associated with a mutation in beta-myosin heavy chain.
    Ware SM; Quinn ME; Ballard ET; Miller E; Uzark K; Spicer RL
    Clin Genet; 2008 Feb; 73(2):165-70. PubMed ID: 18076673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiomyopathies due to defective energy metabolism: morphological and functional features].
    Giordano C; D'Amati G
    Pathologica; 2005 Dec; 97(6):361-8. PubMed ID: 16619977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manipulating the contractile apparatus: genetically defined animal models of cardiovascular disease.
    Dalloz F; Osinska H; Robbins J
    J Mol Cell Cardiol; 2001 Jan; 33(1):9-25. PubMed ID: 11133219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.